Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Promino Nutritional Sciences Inc. C.MUSL

Alternate Symbol(s):  MUSLF

Promino Nutritional Sciences Inc., formerly Element Nutritional Sciences Inc., is a research-driven Canadian nutraceutical company. The Company is specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. The Company's lead product, Rejuvenate, is a formulation that is clinically proven to assist in the building, rebuilding, restoration, and rejuvenation of natural muscle mass. Rejuvenate helps boost energy and strengthen the metabolism and immune system. The Company also offers Promino, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury.


CSE:MUSL - Post by User

Post by waves1on Apr 29, 2022 5:26pm
97 Views
Post# 34643804

$ELMT deemed "Best Ultra Growth Stock for 2022"

$ELMT deemed "Best Ultra Growth Stock for 2022"
Great interview with Element Nutritional Sciences ($ELMT.c $ELNSF) CEO Stuart Lowther from Independent Investor:
https://www.youtube.com/watch?v=ngp4jbG-oCs&ab_channel=IndependentInvestor
 
Clinically proven to improve muscle health, prevent muscle loss and help build lean muscle, $ELMT's patented formulations target muscle loss due to aging. 
 
$ELMT is uniquely positioned to capitalize on the large but underserviced consumer market of those ages 45 and up. Plus, with over 18 years of research and 28 published clinical studies, $ELMT's products blow any competitors out of the water.  
<< Previous
Bullboard Posts
Next >>